{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:01:47Z","timestamp":1791118907454,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.brainres.2004.08.015","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T17:15:35Z","timestamp":1095182135000},"page":"95-107","source":"Crossref","is-referenced-by-count":42,"title":["Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease"],"prefix":"10.1016","volume":"1026","author":[{"given":"Hong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Ebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Michotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2004.08.015_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0028-3908(01)00178-2","article-title":"Continuous subcutaneous infusion of apomorphine rescues nigrostriatal dopaminergic terminals following MPTP injection in mice","volume":"42","author":"Battaglia","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2004.08.015_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0361-9230(91)90242-C","article-title":"Retrograde degeneration of nigrostriatal neurons induced by intrastriatal injection in rats","volume":"26","author":"Berger","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2004.08.015_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/nbdi.1997.0151","article-title":"Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease","volume":"4","author":"Bjorklund","year":"1997","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.brainres.2004.08.015_bib4","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1523\/JNEUROSCI.15-07-05372.1995","article-title":"Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism","volume":"15","author":"Borlongan","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2004.08.015_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-8993(97)00817-2","article-title":"Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats","volume":"771","author":"Caldwell","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1353-8020(00)00061-4","article-title":"Neuroprotective effects of D3 dopamine receptor agonists","volume":"7","author":"Carvey","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2004.08.015_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jnnp.64.5.573","article-title":"Continuous subcutaneous waking day apomorphine in the long-term treatment of levodopa induced interdose dyskinesias in Parkinson's disease","volume":"64","author":"Colzi","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2004.08.015_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.brainres.2004.08.015_bib9","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1460-9568.2003.03014.x","article-title":"Microglial activation with a typical proinflammatory cytokine expression in a rat model of Parkinson's disease","volume":"18","author":"Depino","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2004.08.015_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02246662","article-title":"Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine","volume":"124","author":"Depoortere","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2004.08.015_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0006-8993(97)00630-6","article-title":"Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine","volume":"767","author":"Dluzen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0006-8993(87)90967-X","article-title":"The crossed nigrostriatal projection decussates in the ventral tegmental decussation","volume":"418","author":"Douglas","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib13","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1523\/JNEUROSCI.01-12-01361.1981","article-title":"Collateralization of monoamine neurons: mesotelencephalic dopamine projections to caudate, septum, and frontal cortex","volume":"1","author":"Fallon","year":"1981","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2004.08.015_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(00)00009-9","article-title":"Axonal sprouting following lesions of the rat substantia nigra","volume":"97","author":"Finkelstein","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2004.08.015_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(01)02125-4","article-title":"Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage","volume":"898","author":"Fornai","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(96)00291-9","article-title":"Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction","volume":"308","author":"Gassen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2004.08.015_bib17","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0306-4522(02)00385-8","article-title":"Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia","volume":"115","author":"Grant","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2004.08.015_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6","article-title":"Apomorphine protects against MPTP-induced neurotoxicity in mice","volume":"14","author":"Grunblatt","year":"1999","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2004.08.015_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2001.00397.x","article-title":"Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine","volume":"78","author":"Grunblatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.08.015_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1471-4159.2001.t01-1-00227.x","article-title":"Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss","volume":"77","author":"Grunblatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.08.015_bib21","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1460-9568.2002.02256.x","article-title":"Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures","volume":"16","author":"Guo","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2004.08.015_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-8993(91)90481-A","article-title":"Degeneration of the nigral dopamine neurons after 6-OHDA injection into the rat striatum","volume":"549","author":"Ichitani","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/exnr.1994.1205","article-title":"Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra","volume":"130","author":"Ichitani","year":"1994","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2004.08.015_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.0022-3042.2001.00694.x","article-title":"Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease","volume":"80","author":"Ikeda","year":"2002","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.brainres.2004.08.015_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(98)00393-8","article-title":"Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of l-dopa in hemi-Parkinson rats","volume":"353","author":"Izurieta-Sanchez","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.08.015_bib26","series-title":"Neurodegeneration and Neuroprotection in Parkinson's Disease","first-page":"24","article-title":"Pathological evidence for oxidative stress in Parkinson' s disease and related degenerative disorders","author":"Jenner","year":"1996"},{"issue":"18","key":"10.1016\/j.brainres.2004.08.015_bib27","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.17-18-07111.1997","article-title":"GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis","volume":"17","author":"Kearns","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2004.08.015_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioural and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-OHDA in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2004.08.015_bib29","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1046\/j.1460-9568.2000.00274.x","article-title":"Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor","volume":"12","author":"Kirik","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2004.08.015_bib30","series-title":"The rat brain\u2014A stereotaxic atlas of the forebrain and lower parts of the brain stem","author":"Konig","year":"1963"},{"issue":"3","key":"10.1016\/j.brainres.2004.08.015_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat","volume":"72","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2004.08.015_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0006-8993(99)01688-1","article-title":"Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist","volume":"838","author":"Lida","year":"1999","journal-title":"Brain Res."},{"issue":"5592","key":"10.1016\/j.brainres.2004.08.015_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1074549","article-title":"Subthalamic GAD gene therapy in a Parkinson's disease rats model","volume":"298","author":"Luo","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.brainres.2004.08.015_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(02)03694-6","article-title":"Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat","volume":"958","author":"Marti","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0091-3057(02)00842-0","article-title":"Evaluation of the mGluR2\/3 agonist LY379268 in rodent models of Parkinson's disease","volume":"73","author":"Murray","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2004.08.015_bib36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1124\/jpet.103.049445","article-title":"LY503430, a novel AMPA-potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease","volume":"306","author":"Murray","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2004.08.015_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0006-8993(02)02934-7","article-title":"Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioural, biochemical and histochemical measurements in a model of progressive Parkinson's disease","volume":"947","author":"Oiwa","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2004.08.015_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(98)00866-X","article-title":"Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatum","volume":"810","author":"Opacka-Juffry","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib40","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.brainres.2004.08.015_bib41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0014-2999(98)00896-6","article-title":"Functional potencies of new antiparkinsonian drugs at recombinant human D1, D2, and D3 receptors","volume":"366","author":"Perachon","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2004.08.015_bib42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","volume":"67","author":"Przedborski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2004.08.015_bib43","first-page":"1231","article-title":"Neuroprotective agents for clinical trials in Parkinson's disease. A systematic assessment","volume":"2","author":"Ravina","year":"2003","journal-title":"Am. Acad. Neurol."},{"key":"10.1016\/j.brainres.2004.08.015_bib44","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1046\/j.1471-4159.2001.00088.x","article-title":"Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum","volume":"76","author":"Roceri","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.08.015_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0031-9384(02)00753-9","article-title":"Efficacy of elevated body swing test in the early model of Parkinson's disease in rat","volume":"76","author":"Roghani","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2004.08.015_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02251227","article-title":"Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in parkinsonism","volume":"10","author":"Sam","year":"1995","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2004.08.015_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1471-4159.2004.02471.x","article-title":"In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine lesioned rats","volume":"90","author":"Sarre","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.08.015_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"issue":"suppl. 3","key":"10.1016\/j.brainres.2004.08.015_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1468-1331.9.s3.9.x","article-title":"Dopamine agonists and neuroprotection in Parkinson's disease","volume":"9","author":"Schapira","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2004.08.015_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-OHDA lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2004.08.015_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(97)00075-9","article-title":"Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats","volume":"754","author":"Sethy","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.08.015_bib52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/exnr.1994.1054","article-title":"A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioural characterization","volume":"126","author":"Thomas","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2004.08.015_bib53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0891-5849(93)90055-Y","article-title":"Iron-reducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines","volume":"15","author":"Ubeda","year":"1993","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2004.08.015_bib54","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1471-4159.1994.62031034.x","article-title":"Antioxidant properties of bromocriptine, a dopamine agonist","volume":"62","author":"Yoshikawa","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.08.015_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1999.tb07977.x","article-title":"The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators","volume":"890","author":"Youdim","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"13","key":"10.1016\/j.brainres.2004.08.015_bib56","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1073\/pnas.1131955100","article-title":"Evidence for neurogenesis in the adult mammalian substantia nigra","volume":"100","author":"Zhao","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899304013320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899304013320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:50:29Z","timestamp":1549241429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899304013320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0006899304013320"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2004.08.015","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}